Clinical Trial Update: A Clinical Trial of Chidamide in the Management of Refractory ITP [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating chidamide for immune thrombocytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Shandong University | Conditions: Thrombocytopenia | Phase 1, Phase 2 | Status: COMPLETED